Variations in indicators of the health sector and the pharmaceutical market in Russia during 2020

• Alla Ivanovna Ovod Department of “Management and economics of pharmacy” Kursk State Medical University Kursk, Russia http://orcid.org/0000-0001-9380-1138
• Tatyana Anatolievna Oleynikova Department of “Management and Economics of Pharmacy” Kursk State Medical University Kursk, Russia. http://orcid.org/0000-0001-7354-8286
• Tatyana Ivanovna Urusova Department of “Management and Economics of Pharmacy” Kursk State Medical University Kursk, Russia http://orcid.org/0000-0003-3492-5514
• Tatyana Vasilievna Reztsova Department of “Management and Economics of Pharmacy” Kursk State Medical University Kursk, Russia. http://orcid.org/0000-0003-2808-9847
• Vladimir Olegovich Ulyanov Department of “Management and Economics of Pharmacy” Kursk State Medical University Kursk, Russia http://orcid.org/0000-0003-3522-4197
• Olga Valentinovna Menshikova Department of “Management and Economics of Pharmacy” Kursk State Medical University Kursk, Russia http://orcid.org/0000-0003-1825-7077

DOI: https://doi.org/10.46925//rdluz.33.25

Keywords: healthcare; pharmaceutical market; coronavirus; morbidity, drug sales volume; weighted average drug prices; drug sales structure

Abstract

The study aimed to evaluate the influence of coronavirus on the functioning of the system of healthcare and the associated pharmaceutical industry in Russia. The study of the influence of coronavirus infection on the system of healthcare and pharmaceutical market in Russia was made using a statistical method of comparison of the parameters. The degree of influence on the system of healthcare was estimated by the monthly dynamic of the morbidity rate, which reflected the load on medical institutions of the budgetary system of healthcare of the RF. The changes on the pharmaceutical market were evaluated through quantitative and price factors: quantitative factor was defined by the dynamics of general volume of sales and price – by the changes of the average-weighted prices on the market. As a result, it was established that the dynamics of the morbidity rate with coronavirus in Russia varied wavelike, significantly increasing in the periods of pandemic peaks in May and December 2020. This indicates that the system of healthcare lacks mechanisms of fighting the infection spread in complicated epidemiologic conditions, the bed capacity is low, and there is a deficit in medical personnel. During pandemics, a significant increase in the drug cost was observed on the pharmaceutical market. Especially, it was evident for drugs used to limit the spread of coronavirus, which was confirmed by the shift of drugs sales to the group of antimicrobials. Coronavirus pandemic significantly affected the structure and tendencies in the development of healthcare and Russian pharmaceutical market.

References

DSM Group. Analytical reviews of the Russian pharmaceutical market. Available at: https://dsm.ru/marketing/free-information/analytic-reports/.

Dubois, P. and Sæthre, M. (2020). On the Effect of Parallel Trade on Manufacturers' and Retailers' Profits in the Pharmaceutical Sector. Econometrica, 88, 2503-2545.

Dubois, P., de Mouzon, O., Scott‐Morton, F. and Seabright, P. (2015). Market size and pharmaceutical innovation. The RAND Journal of Economics, 46, 844-871. DOI: https://doi.org/10.1111/1756-2171.12113

Dynkin, A. A. and Telegina, E. A. (2020). Pandemic shock and post-crisis world. World Economy and International Relations, 64 (8), 5-16.

Finol Romero, L. (2021). Transparencia y Gobernanza en la Gestión de la Crisis de COVID-19. Cuestiones Políticas, 39 (68), 23-50. https://produccioncientificaluz.org/index.php/cuestiones/article/view/35390

Kolodko, G. V. (2020). Effects, economics and politics in the post-pandemic world. Problems of Economics, 5, 25-44.

Krivenko, N. V., Elishev, V. G. and Kriventsova, L. A. (2019). The influence of innovations on the effectiveness of health care in the system of economic security of the region. Economy of the region, 15 (1), 164-177.

Krivenko, N. V. and Tsvetkov, A. I. (2018). The effectiveness of health care financing to ensure the economic security of the region. Economy of the region, 14 (3), 970-986.

Kudelina, O. V. and Eremina, S. L. (2016). Regional healthcare effectiveness. Economy of Region, 12 (1), 211-225.

Margaret, K. K. (2020). The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals. Innovation Policy and the Economy, 20 (1), 95-123. DOI: 10.1086/705640

Mensa Sorato, M., Davari, M., Abdollahi Asl, A., Soleymani, F. and Kebriaeezadeh, A. (2020). Why healthcare market needs government intervention to improve access to essential medicines and healthcare efficiency: a scoping review from pharmaceutical price regulation perspective. Journal of Pharmaceutical Health Services Research, 11, 321-333.

Ovod, A. I. (2020). On the development of the pharmaceutical market of the Russian Federation under sanctions. Azimuth of scientific research: economics and management, 9, 1 (30), 252-255.

Pinkovetskaia, I., Lyubovtseva, E., Arbeláez-Campillo, D., & Rojas-Bahamón, M. (2020). Small and medium enterprises in Russia and other countries. Amazonia Investiga 9 (25), 99-106. Retrieved from https://amazoniainvestiga.info/index.php/amazonia/article/view/1034

Polbin, A. V., Sinelnikov-Murylev, S. G., Trunin, P. V. (2020). Economic crisis of 2020: causes and measures to overcome it and further development of Russia. Economic Issues, 6, 5-21.

Reprintseva, E. V. (2020a). Analysis of the indicators of the hospital network of the healthcare system of the Russian Federation. Azimuth of scientific research: economics and management, 9, 2 (31), 281-284.

Reprintseva, E. V. (2020b). Import dependence of the Russian pharmaceutical market as a threat to drug safety. Azimuth of scientific research: economics and management, 9, 1 (30), 292-294.

Rospotrebnadzor RF. Actual epidemic situation in Russia and the world. Available at: https://www.rospotrebnadzor.ru/region/korono_virus/epid.php.

Sergeeva, N. M. (2020). The growth of healthcare financing in the budget structure as a guarantee of improving the quality of medical services. Azimuth of scientific research: economics and management, 9, 1 (30), 305-308.

Ushkalova, D. I. (2020). Foreign trade of Russia in new conditions. Journal of a new economic association, 1 (45), 199-207.

Zhang, H., Zaric, G. S. and Huang, T. (2011). Optimal Design of a Pharmaceutical Price–Volume Agreement Under Asymmetric Information About Expected Market Size. Production and Operations Management, 20, 334-346.

Zyukin, D. A., Bystritskaya, A. B., Golovin, A. A. and Vlasova, O. V. (2020a). The share of health care spending in the structure of GDP as a criterion for the healthcare system effectiveness, 11 (30), 352-363.

Zyukin, D., Golovin, A., Pshenichnikova, O. and Nadzhafova, M. (2020b). Assessing the functionality of models for predicting pharmaceutical companies. Amazonia Investiga, 9 (28), 272-280.